Metabolic phenotyping via administration of probe for HMG CoA reductase inhibitor (hydroxy-3-methylglutaryl/3-coenzyme A); comprises microgravimetric sensors
公开/公告号：
US20030053950 A1
公开/公告日期：
Mar 20, 2003
被引量：
摘要：
The invention relates to the individualization of therapy on the basis of a phenotypic profile of an individual. More specifically, the present invention relates to the use of metabolic phenotyping for the individualization of treatment with hyperlipidemia agents.
展开
通过文献互助平台发起求助，成功后即可免费获取论文全文。
请先登入
相似文献
参考文献
引证文献
引用走势
2006
被引量：2
辅助模式
0
引用
文献可以批量引用啦~
欢迎点我试用！
